Anthony J Weier

Array ( [id] => 4041684 [patent_doc_number] => 05874299 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Transgenic non-human animals capable of producing heterologous antibodies' [patent_app_type] => 1 [patent_app_number] => 8/800353 [patent_app_country] => US [patent_app_date] => 1997-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 35 [patent_no_of_words] => 36663 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874299.pdf [firstpage_image] =>[orig_patent_app_number] => 800353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937243 [patent_doc_number] => 05976524 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Chimeric kidney' [patent_app_type] => 1 [patent_app_number] => 8/797201 [patent_app_country] => US [patent_app_date] => 1997-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4745 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976524.pdf [firstpage_image] =>[orig_patent_app_number] => 797201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937051 [patent_doc_number] => 05871968 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'P21.sup.WAF1 derivatives and diagnostic methods' [patent_app_type] => 1 [patent_app_number] => 8/795015 [patent_app_country] => US [patent_app_date] => 1997-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 52 [patent_no_of_words] => 11397 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871968.pdf [firstpage_image] =>[orig_patent_app_number] => 795015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4232700 [patent_doc_number] => 06074842 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Cloning of perilipin proteins' [patent_app_type] => 1 [patent_app_number] => 8/767579 [patent_app_country] => US [patent_app_date] => 1996-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 26 [patent_no_of_words] => 26297 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/074/06074842.pdf [firstpage_image] =>[orig_patent_app_number] => 767579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086234 [patent_doc_number] => 06025339 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Composition, kit and method for treatment of disorders associated with bronchoconstriction and lung inflammation' [patent_app_type] => 1 [patent_app_number] => 8/757024 [patent_app_country] => US [patent_app_date] => 1996-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 10 [patent_no_of_words] => 19415 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025339.pdf [firstpage_image] =>[orig_patent_app_number] => 757024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4085122 [patent_doc_number] => 06054632 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Method of making monoclonal antibodies using polymorphic transgenic animals' [patent_app_type] => 1 [patent_app_number] => 8/749527 [patent_app_country] => US [patent_app_date] => 1996-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8570 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054632.pdf [firstpage_image] =>[orig_patent_app_number] => 749527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4187815 [patent_doc_number] => 06150584 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Human antibodies derived from immunized xenomice' [patent_app_type] => 1 [patent_app_number] => 8/724752 [patent_app_country] => US [patent_app_date] => 1996-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 26 [patent_no_of_words] => 14453 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150584.pdf [firstpage_image] =>[orig_patent_app_number] => 724752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4033915 [patent_doc_number] => 05856178 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'DNA cassettes for expression of lytic peptides in mammalian cells and transgenic organisms containing same' [patent_app_type] => 1 [patent_app_number] => 8/723306 [patent_app_country] => US [patent_app_date] => 1996-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 11758 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856178.pdf [firstpage_image] =>[orig_patent_app_number] => 723306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4150337 [patent_doc_number] => 06063983 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Monoclonal lymphocytes and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/707743 [patent_app_country] => US [patent_app_date] => 1996-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 19 [patent_no_of_words] => 36848 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063983.pdf [firstpage_image] =>[orig_patent_app_number] => 707743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3983117 [patent_doc_number] => 05958892 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => '2-methoxyestradiol-induced apoptosis in cancer cells' [patent_app_type] => 1 [patent_app_number] => 8/688613 [patent_app_country] => US [patent_app_date] => 1996-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 16286 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958892.pdf [firstpage_image] =>[orig_patent_app_number] => 688613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3983103 [patent_doc_number] => 05958891 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Recombinant eukaryotic plasmids containing allergen-gene and use thereof for the prevention and/or treatment of allergic diseases' [patent_app_type] => 1 [patent_app_number] => 8/682837 [patent_app_country] => US [patent_app_date] => 1996-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7130 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958891.pdf [firstpage_image] =>[orig_patent_app_number] => 682837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4244975 [patent_doc_number] => 06136595 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Jak kinases and regulations of cytokine signal transduction' [patent_app_type] => 1 [patent_app_number] => 8/665574 [patent_app_country] => US [patent_app_date] => 1996-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 59014 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136595.pdf [firstpage_image] =>[orig_patent_app_number] => 665574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3872394 [patent_doc_number] => 05804159 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-08 [patent_title] => 'Antiplasma animal model' [patent_app_type] => 1 [patent_app_number] => 8/663031 [patent_app_country] => US [patent_app_date] => 1996-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6499 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/804/05804159.pdf [firstpage_image] =>[orig_patent_app_number] => 663031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937169 [patent_doc_number] => 05972900 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Delivery of nucleic acid to cells' [patent_app_type] => 1 [patent_app_number] => 8/655705 [patent_app_country] => US [patent_app_date] => 1996-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 20 [patent_no_of_words] => 29119 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972900.pdf [firstpage_image] =>[orig_patent_app_number] => 655705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4232017 [patent_doc_number] => 06117676 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'Transfected human amniotic cells and method for producing a gene product' [patent_app_type] => 1 [patent_app_number] => 8/641214 [patent_app_country] => US [patent_app_date] => 1996-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2836 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117676.pdf [firstpage_image] =>[orig_patent_app_number] => 641214 [rel_patent_id] =>[rel_patent_doc_number] =>)